









市场行情
/
股票
/
nasdaq-cdna
/

CareDx Inc

CDNA

14.770USD

+0.470+3.29%

收盘 09/18, 16:00（美东）报价延迟15分钟

786.06M总市值

15.21市盈率 TTM



CareDx Inc

14.770

+0.470+3.29%

概览公司财务分析

CareDx, Inc. 是一家精准医疗解决方案公司。该公司专注于发现、开发和商业化针对移植患者和护理人员的临床差异化诊断解决方案。该公司在移植前后的患者旅程中提供检测服务、产品以及患者和数字解决方案，并为移植患者提供基于基因组学的信息。其商业化的检测服务包括 AlloSure Kidney（一种用于肾移植患者的供体来源的无细胞 DNA (dd-cfDNA) 解决方案）；AlloMap Heart（一种用于心脏移植患者的基因表达解决方案）；AlloSure Heart（一种用于心脏移植患者的 dd-cfDNA 解决方案）和 AlloSure Lung（一种用于肺移植患者的 dd-cfDNA 解决方案）。该公司的产品组合包括 AlloSeq Tx、QTYPE、Olerup SSP、AlloSeq HCT 和 AlloSeq cfDNA。它为各种移植接受者开发并提供诊断监测检测服务。

公司简介

公司代码CDNA

公司名称CareDx Inc

上市日期Jul 17, 2014

CEOMr. John W. Hanna

员工数量644

证券类型Ordinary Share

年结日Jul 17

公司地址8000 Marina Blvd

城市BRISBANE

上市交易所NASDAQ Global Market Consolidated

国家United States of America

邮编94005

电话14152872300

网址https://www.caredx.com/

公司代码CDNA

上市日期Jul 17, 2014

CEOMr. John W. Hanna

公司高管

名称

名称/职务

职务

持股

持股变动

Dr. Peter Maag, Ph.D.

Independent Director

298.28K

-3.24%

Dr. Frederick E. (Fred) Cohen, M.D.

Independent Director

144.69K

+9.13%

Mr. Michael D. Goldberg

Independent Chairman of the Board

143.65K

+0.86%

Ms. Jessica Meng

Chief Commercial Officer

109.63K

-4.11%

Mr. William A. (Bill) Hagstrom

Independent Director

43.41K

Mr. Nathan Smith

Chief Financial Officer

42.00K

Ms. Christine M. Cournoyer

Independent Director

38.58K

+45.71%

Mr. Jeffrey Adam Novack

General Counsel, Secretary

25.20K

-18.08%

Ms. Caroline Corner

Investor Relations

Ms. Jennifer Foley

Chief Product Officer

名称

名称/职务

职务

持股

持股变动

Dr. Peter Maag, Ph.D.

Independent Director

298.28K

-3.24%

Dr. Frederick E. (Fred) Cohen, M.D.

Independent Director

144.69K

+9.13%

Mr. Michael D. Goldberg

Independent Chairman of the Board

143.65K

+0.86%

Ms. Jessica Meng

Chief Commercial Officer

109.63K

-4.11%

Mr. William A. (Bill) Hagstrom

Independent Director

43.41K

Mr. Nathan Smith

Chief Financial Officer

42.00K

收入明细

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Testing Service revenue

61.92M

0.00%

Digital and other revenue

11.95M

0.00%

Product revenue

10.81M

0.00%

地区USD

名称

营收

占比

United States

79.86M

0.00%

Rest of the world

4.82M

0.00%

业务

地区

业务USD

名称

营收

占比

Testing Service revenue

61.92M

0.00%

Digital and other revenue

11.95M

0.00%

Product revenue

10.81M

0.00%

股东统计

更新时间: 8月15日周五

持股股东

股东类型

持股股东

占比

The Vanguard Group, Inc.

9.21%

BlackRock Institutional Trust Company, N.A.

7.64%

Baron Capital Management, Inc.

4.58%

State Street Global Advisors (US)

4.10%

Gagnon Securities LLC

4.01%

其他

70.48%

持股股东

占比

The Vanguard Group, Inc.

9.21%

BlackRock Institutional Trust Company, N.A.

7.64%

Baron Capital Management, Inc.

4.58%

State Street Global Advisors (US)

4.10%

Gagnon Securities LLC

4.01%

其他

70.48%

股东类型

持股股东

占比

Investment Advisor/Hedge Fund

44.31%

Investment Advisor

43.78%

Hedge Fund

10.63%

Individual Investor

3.65%

Research Firm

2.34%

Pension Fund

0.66%

Bank and Trust

0.37%

Insurance Company

0.04%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

458

57.19M

107.22%

-3.81M

2025Q1

463

58.20M

104.56%

-2.86M

2024Q4

457

54.99M

99.23%

-4.48M

2024Q3

452

53.78M

101.72%

-11.43M

2024Q2

424

54.82M

104.96%

-13.18M

2024Q1

450

55.58M

107.13%

-14.92M

2023Q4

462

54.27M

100.29%

-16.52M

2023Q3

493

55.98M

103.34%

-21.97M

2023Q2

517

57.57M

107.02%

-21.82M

2023Q1

532

58.67M

109.28%

-16.17M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

The Vanguard Group, Inc.

4.82M

8.66%

-25.66K

-0.53%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

4.21M

7.56%

-77.53K

-1.81%

Mar 31, 2025

Baron Capital Management, Inc.

2.19M

3.93%

-17.29K

-0.78%

Mar 31, 2025

State Street Global Advisors (US)

2.48M

4.46%

-174.50K

-6.56%

Mar 31, 2025

Gagnon Securities LLC

1.42M

2.55%

-9.51K

-0.66%

Mar 31, 2025

ARK Investment Management LLC

2.35M

4.22%

-61.72K

-2.56%

Mar 31, 2025

Ophir Asset Management Pty Ltd

1.62M

2.91%

+1.62M

Mar 31, 2025

Hood River Capital Management LLC

1.58M

2.84%

+1.58M

Mar 31, 2025

Invesco Advisers, Inc.

1.88M

3.39%

+1.12M

+147.36%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.28M

2.3%

+46.16K

+3.74%

Mar 31, 2025

持股ETF

更新时间: 9月2日周二

机构名称

占比

ARK Genomic Revolution ETF

2.49%

Invesco Biotechnology & Genome ETF

1.9%

ROBO Global Healthcare Technology & Innovation ETF

0.87%

Invesco Dorsey Wright Healthcare Momentum ETF

0.84%

Global X Genomics & Biotechnology ETF

0.78%

Franklin Genomic Advancements ETF

0.29%

First Trust Small Cap Growth AlphaDEX Fund

0.23%

SPDR S&P Biotech ETF

0.22%

VictoryShares US Small Mid Cap Value Momentum ETF

0.16%

iShares Micro-Cap ETF

0.15%

ARK Genomic Revolution ETF

占比2.49%

Invesco Biotechnology & Genome ETF

占比1.9%

ROBO Global Healthcare Technology & Innovation ETF

占比0.87%

Invesco Dorsey Wright Healthcare Momentum ETF

占比0.84%

Global X Genomics & Biotechnology ETF

占比0.78%

Franklin Genomic Advancements ETF

占比0.29%

First Trust Small Cap Growth AlphaDEX Fund

占比0.23%

SPDR S&P Biotech ETF

占比0.22%

VictoryShares US Small Mid Cap Value Momentum ETF

占比0.16%

iShares Micro-Cap ETF

占比0.15%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

KeyAI

